The main mechanisms of anti-tumor activity relies on the drugs’ ability to exert a strong DNA damage and increase MPM cells immunogenicity, activating STING pathway and reshaping MPM immune-environment in an antitumor manner. Here, STING1 is linked to neoplasm.